Lataa...
Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes
We conducted a descriptive case study to examine the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on urinary angiotensinogen excretion, which represents the function of the intrarenal renin–angiotensin system, in patients with type 2 diabetes. An SGLT2 inhibitor (canagliflozin 100 mg...
Tallennettuna:
| Julkaisussa: | J Investig Med |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Journal of Investigative Medicine
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5812257/ https://ncbi.nlm.nih.gov/pubmed/28596160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jim-2017-000445 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|